Dornier MedTech Brings the Most Advanced Kidney Stone Treatment Lithotripter—Dornier Delta® III—to Japan
Dornier MedTech, a global leader in innovative kidney stone management, has received PMDA (Pharmaceuticals and Medical Devices Agency) regulatory approval to market the Delta® III in Japan. This is the latest generation of the world’s best-selling and most clinically cited lithotripter, the Delta II.
View More
Atlanta, America, 25 April 2019
Dornier MedTech (Dornier), a global urology company and a leader in kidney stone management, today announced the launch and immediate availability of its new AXIS™ Single-Use Digital Flexible Ureteroscope (AXIS™) and Stone Management Products in the United States. The products will be showcased at the upcoming 2019 American Urology Association Meeting in Chicago on 3 – 5 May 2019.
View More
We can’t wait to share about our products with you! Product and brochure availability may vary between countries, but we’ll be in touch.
Fill out the form below to receive the download link.